Kifa Therapeutics is a preclinical-stage biotechnology company developing precision medicines for Parkinson’s disease. Our lead program targets the G2019S mutation in the LRRK2 gene with a highly selective small-molecule inhibitor, aiming to slow or halt disease progression. We are backed by leading... Read more
Employees
1-10Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
